Comparison |
| Alternate Manufacturer Number |
2008720 | 2008712 |
| Generic Drug Code |
33188 | 33187 |
| NDC Number |
00456120230 | 00456120130 |
| Strength |
290 mg | 145 mcg |
| Application |
Irritable Bowel Syndrome with Constipation (IBS-C) Treatment | Irritable Bowel Syndrome with Constipation (IBS-C) Treatment |
| Container Type |
Bottle | Bottle |
| Country of Origin |
Unknown | Unknown |
| Dosage Form |
Capsule | Capsule |
| Generic Drug Name |
Linaclotide | Linaclotide |
| Product Dating |
McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days |
| UNSPSC Code |
51172337 | 51172337 |
| Volume |
30 Capsules | 30 Capsules |
| Features and Benefits |
- LINZESS® (linaclotide) is a prescription medication used in adults to treat irritable bowel syndrome with constipation (IBS‑C) and chronic idiopathic constipation (CIC)
- Do not give LINZESS to children who are under 6 years of age - It may harm them
- You should not give LINZESS to children 6 to 17 years of age - It may harm them
|
- LINZESS® (linaclotide) is a prescription medication used in adults to treat irritable bowel syndrome with constipation (IBS‑C) and chronic idiopathic constipation (CIC)
- Do not give LINZESS to children who are under 6 years of age - It may harm them
- You should not give LINZESS to children 6 to 17 years of age - It may harm them
|
